[Treatment of severe Behçet's disease with anti-TNF-alpha: infliximab. A case report].
Andreu
Marita
M
Service de Médecine Interne, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Université Paris-Nord, UPRES EA 3409, 125, rue de Stalingrad, 93000 Bobigny, France.
Ramanoelina
Jacky
J
Fajnkuchen
Franck
F
Mouthon
Luc
L
Cohen
Pascal
P
Laroche
Liliane
L
Guillevin
Loïc
L
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab